⚠ You're viewing a report from March 2023. Subscribe to get the latest →

FDA Enforcement — March 2023 Report

Automated analysis of 30 items from public government data sources. Updated daily.

Summary

30
Total items
25
High impact
5
Medium impact
0
Low impact

High-impact items this period

Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy
Compounding pharmacy producing adulterated drug products
Why: Manufacturing control deficiencies in compounding operations  ·  Mar 31  ·  Impact: HIGH
ALI Pharmaceutical Manufacturing, LLC
Active pharmaceutical ingredient adulteration CGMP violation
Why: API manufacturing fails current good manufacturing practice standards  ·  Mar 30  ·  Impact: HIGH
Sure-Biochem Laboratories, LLC
Current Good Manufacturing Practice violations in pharmaceuticals
Why: Adulterated finished pharmaceutical products due to manufacturing defects  ·  Mar 24  ·  Impact: HIGH
Liberty Fruit Co. Inc. DBA Carol’s Cuts
Juice HACCP, CGMP violations; adulteration and insanitary conditions
Why: Unsanitary manufacturing conditions; product contamination risks  ·  Mar 24  ·  Impact: HIGH
Synovo Production, Inc.
CGMP and quality system violations in medical device manufacturing
Why: Non-compliance with quality system regulation in device production  ·  Mar 23  ·  Impact: HIGH
Tyrone L. McCall, M.D./Cornea Associates of Texas
Clinical investigator violations in drug research protocols
Why: Non-compliance with clinical trial conduct and data integrity requirements  ·  Mar 22  ·  Impact: HIGH
Omega Packaging Corp
CGMP violations in finished pharmaceutical manufacturing
Why: Quality control deficiencies in pharmaceutical product packaging and production  ·  Mar 20  ·  Impact: HIGH
Old Europe Cheese, Inc.
Cheese produced under insanitary conditions causing adulteration
Why: Inadequate sanitation and contamination control in dairy processing  ·  Mar 17  ·  Impact: HIGH
www.ivermectin4covid.com
Unlawful sale of unapproved drugs via internet
Why: Online sales of unapproved ivermectin products to US consumers  ·  Mar 16  ·  Impact: HIGH
ALL-IN Vapors
Tobacco products adulterated and misbranded
Why: Non-compliance with Family Smoking Prevention Control Act  ·  Mar 16  ·  Impact: HIGH

Selected medium-impact items

Stuff N Puffs 101, LLC d/b/a Stuff-N-Puffs
Tobacco products adulterated and misbranded under FSPTCA
Why: Products violated Family Smoking Prevention and Tobacco Control Act requirements  ·  Mar 23  ·  Impact: MEDIUM
Marina Technology LLC
Tobacco products adulterated and misbranded under FSPTCA
Why: Products violated Family Smoking Prevention and Tobacco Control Act requirements  ·  Mar 16  ·  Impact: MEDIUM
Procter & Gamble Manufactura S. de R.L. de C.V.
Failure to register and list drug products with FDA
Why: Company did not complete required FDA registration and listing procedures  ·  Mar 14  ·  Impact: MEDIUM
J&H Imports Services Corp
Foreign Supplier Verification Program compliance failure
Why: Inadequate verification procedures for imported food products  ·  Mar 13  ·  Impact: MEDIUM
Maggie Jeffries, M.D. / Avanti Anesthesiology, LLC
Clinical investigator compliance violations
Why: Non-compliance with clinical investigator regulatory requirements  ·  Mar 03  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →